127 related articles for article (PubMed ID: 12031798)
1. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression.
Shin M; Yan C; Boyd D
Biochim Biophys Acta; 2002 May; 1589(3):311-6. PubMed ID: 12031798
[TBL] [Abstract][Full Text] [Related]
2. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
Gum R; Wang H; Lengyel E; Juarez J; Boyd D
Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
[TBL] [Abstract][Full Text] [Related]
3. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
[TBL] [Abstract][Full Text] [Related]
5. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
[TBL] [Abstract][Full Text] [Related]
6. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation.
Yan C; Wang H; Boyd DD
J Biol Chem; 2001 Jan; 276(2):1164-72. PubMed ID: 11060311
[TBL] [Abstract][Full Text] [Related]
7. Ginsenoside Rh1 suppresses matrix metalloproteinase-1 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathway in human hepatocellular carcinoma cells.
Yoon JH; Choi YJ; Lee SG
Eur J Pharmacol; 2012 Mar; 679(1-3):24-33. PubMed ID: 22314224
[TBL] [Abstract][Full Text] [Related]
8. IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes.
Wu CY; Hsieh HL; Sun CC; Yang CM
Glia; 2009 Dec; 57(16):1775-89. PubMed ID: 19455716
[TBL] [Abstract][Full Text] [Related]
9. EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells.
Kim HS; Kim MH; Jeong M; Hwang YS; Lim SH; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2004; 24(2B):747-53. PubMed ID: 15161022
[TBL] [Abstract][Full Text] [Related]
10. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
Simon C; Simon M; Vucelic G; Hicks MJ; Plinkert PK; Koitschev A; Zenner HP
Exp Cell Res; 2001 Dec; 271(2):344-55. PubMed ID: 11716547
[TBL] [Abstract][Full Text] [Related]
11. Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Hwang YP; Yun HJ; Choi JH; Kang KW; Jeong HG
Mol Nutr Food Res; 2010 Jul; 54(7):977-90. PubMed ID: 19943262
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Simon C; Goepfert H; Boyd D
Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation protein-1, and NF-kappa B transcription factors.
Ma W; Gee K; Lim W; Chambers K; Angel JB; Kozlowski M; Kumar A
J Immunol; 2004 Jan; 172(1):318-30. PubMed ID: 14688340
[TBL] [Abstract][Full Text] [Related]
14. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades.
Lakka SS; Jasti SL; Kyritsis AP; Yung WK; Ali-Osman F; Nicolson GL; Rao JS
Clin Exp Metastasis; 2000; 18(3):245-52. PubMed ID: 11315098
[TBL] [Abstract][Full Text] [Related]
15. ERK signaling pathway is involved in p15INK4b/p16INK4a expression and HepG2 growth inhibition triggered by TPA and Saikosaponin a.
Wen-Sheng W
Oncogene; 2003 Feb; 22(7):955-63. PubMed ID: 12592382
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor signaling activates the human interstitial collagenase promoter via the bipartite Ets-AP1 element.
Newberry EP; Willis D; Latifi T; Boudreaux JM; Towler DA
Mol Endocrinol; 1997 Jul; 11(8):1129-44. PubMed ID: 9212060
[TBL] [Abstract][Full Text] [Related]
17. Selective loss of PMA-stimulated expression of matrix metalloproteinase 1 in HaCaT keratinocytes is correlated with the inability to induce mitogen-activated protein family kinases.
Sudbeck BD; Baumann P; Ryan GJ; Breitkopf K; Nischt R; Krieg T; Mauch C
Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):167-75. PubMed ID: 10085241
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
19. CADPE inhibits PMA-stimulated gastric carcinoma cell invasion and matrix metalloproteinase-9 expression by FAK/MEK/ERK-mediated AP-1 activation.
Han H; Du B; Pan X; Liu J; Zhao Q; Lian X; Qian M; Liu M
Mol Cancer Res; 2010 Nov; 8(11):1477-88. PubMed ID: 21047770
[TBL] [Abstract][Full Text] [Related]
20. v-src activation of the collagenase-1 (matrix metalloproteinase-1) promoter through PEA3 and STAT: requirement of extracellular signal-regulated kinases and inhibition by retinoic acid receptors.
Vincenti MP; Schroen DJ; Coon CI; Brinckerhoff CE
Mol Carcinog; 1998 Mar; 21(3):194-204. PubMed ID: 9537651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
